Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Down 57.3% in January

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totaling 9,188 shares, a decline of 57.3% from the December 31st total of 21,517 shares. Based on an average trading volume of 29,690 shares, the short-interest ratio is presently 0.3 days. Currently, 0.7% of the shares of the company are sold short. Currently, 0.7% of the shares of the company are sold short. Based on an average trading volume of 29,690 shares, the short-interest ratio is presently 0.3 days.

Arcadia Biosciences Trading Down 3.7%

Shares of NASDAQ RKDA traded down $0.08 during mid-day trading on Thursday, reaching $2.10. 49,487 shares of the company’s stock were exchanged, compared to its average volume of 30,715. Arcadia Biosciences has a twelve month low of $1.76 and a twelve month high of $6.71. The business has a fifty day simple moving average of $2.98 and a 200 day simple moving average of $3.61. The firm has a market capitalization of $2.88 million, a price-to-earnings ratio of 0.83 and a beta of 0.57.

Arcadia Biosciences (NASDAQ:RKDA) last posted its quarterly earnings data on Friday, November 7th. The basic materials company reported $0.62 earnings per share for the quarter, topping the consensus estimate of ($0.54) by $1.16. The company had revenue of $1.30 million during the quarter, compared to analysts’ expectations of $1.90 million. Arcadia Biosciences had a negative return on equity of 8.80% and a negative net margin of 97.97%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Arcadia Biosciences has a consensus rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.